Oric Pharmaceuticals Inc (ORIC) Stock Analysis

Oric Pharmaceuticals Inc (ORIC) is a publicly traded company in the HEALTHCARE sector. It trades at $7.62, carries a market capitalization of $929.59M. This page summarizes the public market data, fundamentals, and frequently asked questions for ORIC, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Oric Pharmaceuticals Inc currently has a Neutral sentiment score of 0.07.

About Oric Pharmaceuticals Inc

Oric Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, dedicated to the discovery and development of innovative cancer therapies. Utilizing its proprietary drug development platforms, Oric targets significant unmet medical needs in oncology, particularly concerning resistance to existing treatments. The company's promising pipeline, which includes candidates designed to inhibit specific mechanisms of cancer cell survival, pos...

GNG Research Analysis

GNG Research scores Oric Pharmaceuticals Inc (ORIC) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ORIC.

Frequently Asked Questions

Does ORIC pay dividends?

Oric Pharmaceuticals Inc (ORIC) does not currently pay a regular dividend.

What is ORIC's market cap?

Oric Pharmaceuticals Inc (ORIC) has a market capitalization of $929.59M with a current stock price of $7.62.